Delivery Order SPE2DB22D3004-SPE2DB25FQS64

Award Date 5/15/25
Potential Completion Date 5/16/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The contract is for the delivery of "REFRESH PLUS 0.5% EYE DROPS UD 50S" medical supplies, with a ceiling value of $3,191.04 and a completion date of August 1, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,420.55, is for the delivery of "REFRESH PLUS 0.5% EYE DROPS UD 70S" and has a completion date of June 26, 2024. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which is valued at $999,999,999 and runs through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S", a pharmaceutical product, with a ceiling value of $2,413.19 and a period of performance through March 12, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp also holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S", a pharmaceutical product, with a ceiling value of $1,867.19 and a completion date of May 2, 2024. The contract is a firm-fixed price type and does not have a set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S." The contract has a ceiling value of $3,097.72 and a period of performance through July 19, 2024. The contract is a firm-fixed-price, non-set-aside award. Amerisourcebergen, through its Corporate Office division, is responsible for delivering the requested eye drops to support federal...
This federal contract award, valued at $1,354.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REFRESH PLUS 0.5% EYE DROPS 30S, a medical product used for eye care. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S". The award, valued at $3,252.83, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4567845532 REFRESH PLUS 0.5% EYE DROPS 30S, with a ceiling value of $3,387.09 and a completion date of April 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S", with a ceiling value of $1,145.94 and a period of performance through January 9, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,168.13 firm fixed-price delivery order is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 50S" and has a completion date of February 19, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FQS64
    Delivery Order

This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of "REFRESH PLUS 0.5% EYE DROPS 30S", a pharmaceutical product, with a ceiling value of $3,388.44 and a period of performance through May 16, 2025.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) vehicle, designated as SPE2DX, which has a ceiling value of $999,999,999.00 and enables Amerisourcebergen Drug Corp to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. This IDC contract is not set aside and is open to competition.

Generated 8/14/25, 10:01 AM